Description

According to the Market Statsville Group (MSG), the global reverse transcriptase enzyme market size is expected to grow at a CAGR of 3.4% from 2022 to 2030. The reverse transcriptase enzyme market has a huge potential for growth in the forecast period owing to increasing research activities and the high participation of various international research associations to provide better health solutions. Additionally, WHO (World Health Organization) directly participates in various genetic research activities to find better or perfect treatment solutions to the diseases. Moreover, many public and private funds are being raised in different countries to improve healthcare systems. All these factors are expected to drive the market's growth in the coming years. However, high cost, lack of awareness, and availability of the product in some regions may hinder the growth of the reverse transcriptase enzyme market.

Global Reverse Transcriptase Enzyme Market Definition

The reverse transcriptase enzyme is used to form complementary DNA (cDNA). The reverse transcriptase enzyme, also known as RNA-directed DNA polymerase, is encoded from retroviruses that catalyze the transcription of retrovirus RNA (ribonucleic acid) into DNA (deoxyribonucleic acid). The discovery of reverse transcriptase in retroviruses was made by David Baltimore and Howard Temin in 1970, which revolutionized molecular biology and laid the foundations for retrovirology and cancer biology. They also received the 1975 Nobel Prize for Physiology or Medicine. Various research institutions are working to find the process to treat chronic and major diseases using this enzyme.

COVID-19 Impact on the Global Reverse Transcriptase Enzyme Market

The COVID-19 pandemic created havoc worldwide and led to the downfall of many industries. The same applies to the global reverse transcriptase market. The consumer demand was subsequently reduced due to the elimination of non-essential expenses by people severely affected by the outbreak, especially financially. The aforementioned factors are expected to affect the revenue generation by the global reverse transcriptase market over the forecast period. However, as the governing authorities across the world started releasing lockdowns and situations started to normalize, industries became capable of returning to previous operations. Now with the ever-strong healthcare industry created amid covid-19, there is a huge opportunity for the reverse transcriptase enzyme market to grow in the forecast timeline.

Scope of the Global Reverse Transcriptase Enzyme Market

The study categorizes the reverse transcriptase enzyme market based on type, application, and end-user at the regional and global levels.

By Type (Revenue, USD Million, 2017-2030)

• Reagent
• Primer
• Others

By End-User (Revenue, USD Million, 2017-2030)

• Hospitals
• Biotech Companies
• Others

By Application (Revenue, USD Million, 2017-2030)

• Research application
• Medical application
• Others

By Region Outlook (Revenue, USD Million, 2017-2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • Slovenia
  • Slovakia
  • the Netherlands
  • Belgium
  • Norway
  • Denmark
  • Czech Republic
  • Sweden
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Vietnam
  • The Philippines
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

The Research application segment is witnessed to account for the highest market share, by the application

Based on the application, the global reverse transcriptase enzyme market is divided into research applications, medical applications, and others. In 2021, the research application segment accounted for the highest market share in the global reverse transcriptase enzyme market. Due to ongoing research worldwide for the successful treatment of chronic diseases, research application holds the highest market share in the forecast period.

North America accounts for the highest CAGR during the forecast period

Globally, North America is estimated to hold the highest CAGR in the global reverse transcriptase enzyme market during the forecast period. The region includes the countries such as the US, Canada, and Mexico. North America is expected to hold the highest share due to high healthcare expenditure as compared to other regions. The region has advanced research activities conducted by the academic and pharmaceutical industries. The Asia Pacific and Europe also have the scope in the reverse transcriptase enzyme market owing to surging awareness about the product and increasing research activities.

Key Market Players in the Global Reverse Transcriptase Enzyme Market

• Thermo Fisher Scientific
• Bio-Rad Laboratories Inc.
• Clontech Laboratories Inc. (sub. Takara Bio Company)
• Biomatik.
• New England Biolabs
• QIAGEN
• Promega Corporation
• AMS Biotechnology (Europe) Limited
• Cell Sciences

Recent Developments

• In March 2022, Thermo Fisher Scientific introduced two new reverse transcriptions loop-mediated isothermal amplification (RT-LAMP)-based solutions to simplify surveillance of viral pathogens, including SARS-CoV-2. It also designed the new solutions, Invitrogen Colorimetric ReadiLAMP kit, SARS-CoV-2, and Invitrogen SuperScript IV RT-LAMP Master Mix, to support active research of viral pathogens.
• In November 2021, QIAGEN announced the addition of StableScript to its portfolio. The versatile reverse transcriptase is used in one-step RT-qPCR and long-range RT-PCR and is available to order in bulk quantities.
• In November 2020, Bio-Rad Laboratories, Inc. announced the launch of the Reliance Select cDNA Synthesis Kit to help researchers efficiently convert RNA to DNA by reverse transcription.

Key Issues Addressed

• What is the market size by various segmentation of the reverse transcriptase enzyme by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 forces of the reverse transcriptase enzyme market?
• What are the key opportunities and trends for manufacturers involved in the reverse transcriptase enzyme supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the demand and sales of reverse transcriptase enzyme in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.